Co-Authors
This is a "connection" page, showing publications co-authored by Joost Wauters and Katrien Lagrou.
Connection Strength
0.422
-
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2021 Aug 26.
Score: 0.060
-
Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med. 2021 10; 47(10):1158-1160.
Score: 0.060
-
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021 08; 47(8):819-834.
Score: 0.060
-
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies. Br J Haematol. 2021 03; 192(6):1100-1105.
Score: 0.057
-
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Aug; 46(8):1524-1535.
Score: 0.056
-
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018 10; 6(10):782-792.
Score: 0.049
-
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplant Direct. 2017 May; 3(5):e156.
Score: 0.045
-
Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium, 2013. Emerg Infect Dis. 2014 May; 20(5):913-5.
Score: 0.036